{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:42:43Z","timestamp":1771501363982,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12026-020-09126-8","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T16:03:50Z","timestamp":1591373030000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma"],"prefix":"10.1007","volume":"68","author":[{"given":"Reham M.","family":"Abd El-Baky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-7304","authenticated-orcid":false,"given":"Helal F.","family":"Hetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopala","family":"Koneru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Engy A.","family":"Shafik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina A","family":"Mohareb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Abbas El-Masry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidi K.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Zakaria","family":"Abu Rahma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Fawzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustafa","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"9126_CR1","doi-asserted-by":"crossref","unstructured":"Raphael S, Yangde Z, YuXiang C (2012) Hepatocellular carcinoma: focus on different aspects of management ISRN Oncology. 2012. Article ID 421673:12.","DOI":"10.5402\/2012\/421673"},{"key":"9126_CR2","doi-asserted-by":"crossref","unstructured":"Obienu O, Nwokediuko S, Malu A, Lesi OA. Risk factors for hepatitis C virus transmission obscure in nigerian patients. Gastroenterol Res Pract. 2011;2011.","DOI":"10.1155\/2011\/939673"},{"issue":"10","key":"9126_CR3","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/jgh.12936","volume":"30","author":"HF Hetta","year":"2015","unstructured":"Hetta HF, Mekky MA, Khalil NK, Mohamed WA, El-Feky MA, Ahmed SH, et al. Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology. J Gastroenterol Hepatol. 2015;30(10):1543\u201351.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"9126_CR4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1099\/jmm.0.000272","volume":"65","author":"HF Hetta","year":"2016","unstructured":"Hetta HF, Mekky MA, Khalil NK, Mohamed WA, El-Feky MA, Ahmed SH, et al. Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis. J Med Microbiol. 2016;65(8):703\u201312.","journal-title":"J Med Microbiol"},{"issue":"11","key":"9126_CR5","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1007\/s00705-016-3015-4","volume":"161","author":"M Mehta","year":"2016","unstructured":"Mehta M, Hetta HF, Abdel-Hameed EA, Rouster SD, Hossain M, Mekky MA, et al. Association between IL28b rs12979860 single nucleotide polymorphism and the frequency of colonic T reg in chronically HCV-infected patients. Arch Virol. 2016;161(11):3161\u20139.","journal-title":"Arch Virol"},{"issue":"2","key":"9126_CR6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5411\/wji.v4.i2.52","volume":"4","author":"HF Hetta","year":"2014","unstructured":"Hetta HF, Mehta MJ, Shata MTM. Gut immune response in the presence of hepatitis C virus infection. World J Immunol. 2014;4(2):52\u201362.","journal-title":"World J Immunol"},{"key":"9126_CR7","first-page":"45","volume":"25","author":"AM Zahran","year":"2018","unstructured":"Zahran AM, Ashmawy AM, Rayan A, Elkady A, Elsherbiny NM, Hetta HF. Frequency and implications of natural killer and natural killer T cells in hepatocellular carcinoma. Egypt J Immunol. 2018;25:45\u201352.","journal-title":"Egypt J Immunol"},{"issue":"9207","key":"9126_CR8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","volume":"355","author":"C Frank","year":"2000","unstructured":"Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355(9207):887\u201391.","journal-title":"Lancet"},{"issue":"5","key":"9126_CR9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21173","volume":"43","author":"GT Strickland","year":"2006","unstructured":"Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology. 2006;43(5):915\u201322.","journal-title":"Hepatology"},{"issue":"2","key":"9126_CR10","first-page":"307","volume":"41","author":"A El-Sabah","year":"2011","unstructured":"El-Sabah A, El-Metwally M, Abozinadah N. Hepatitis C and B virus in schistosomiasis patients on oral or parenteral treatment. J Egypt Soc Parasitol. 2011;41(2):307\u201314.","journal-title":"J Egypt Soc Parasitol"},{"issue":"7","key":"9126_CR11","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/jmv.25428","volume":"91","author":"HF Hetta","year":"2019","unstructured":"Hetta HF, Zahran AM, Mansor SG, Abdel-Malek MO, Mekky MA, Abbas WA. Frequency and implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma. J Med Virol. 2019;91(7):1319\u201328.","journal-title":"J Med Virol"},{"issue":"7","key":"9126_CR12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.humimm.2019.03.014","volume":"80","author":"AM Zahran","year":"2019","unstructured":"Zahran AM, Nafady-Hego H, Mansor SG, Abbas WA, Abdel-Malek MO, Mekky MA, et al. Increased frequency and FOXP3 expression of human CD8+ CD25High+ T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma. Hum Immunol. 2019;80(7):510\u20136.","journal-title":"Hum Immunol"},{"issue":"1 Suppl","key":"9126_CR13","first-page":"367","volume":"34","author":"M El-Sadawy","year":"2004","unstructured":"El-Sadawy M, Ragab H, El-Toukhy H, el-Mor A-L, Mangoud A, Eissa M, et al. Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors. J Egypt Soc Parasitol. 2004;34(1 Suppl):367\u201384.","journal-title":"J Egypt Soc Parasitol"},{"key":"9126_CR14","doi-asserted-by":"crossref","unstructured":"Kalil K, Farghally H, Hassanein K, Abdel Sayed A, Hassanein F (2010) Hepatitis C virus infection among paediatric patients attending University of Assiut Hospital, Egypt.","DOI":"10.26719\/2010.16.4.356"},{"issue":"4","key":"9126_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333\u201342. https:\/\/doi.org\/10.1002\/hep.26141.","journal-title":"Hepatology"},{"issue":"2","key":"9126_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"D Lavanchy","year":"2011","unstructured":"Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107\u201315.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"9126_CR17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2217\/nnm-2018-0348","volume":"14","author":"NH Abd Ellah","year":"2019","unstructured":"Abd Ellah NH, Tawfeek HM, John J, Hetta HF. Nanomedicine as a future therapeutic approach for hepatitis C virus. Nanomedicine. 2019;14(11):1471\u201391.","journal-title":"Nanomedicine"},{"issue":"6","key":"9126_CR18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cld.111","volume":"1","author":"DA Herbst","year":"2012","unstructured":"Herbst DA, Reddy KR. Risk factors for hepatocellular carcinoma. Clinical Liver Disease. 2012;1(6):180\u20132.","journal-title":"Clinical Liver Disease"},{"issue":"1","key":"9126_CR19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.clinre.2018.08.003","volume":"43","author":"MA Mekky","year":"2019","unstructured":"Mekky MA, Abdel-Malek MO, Osman HA, Abdel-Aziz EM, Hashim A-KA, Hetta HF, et al. Efficacy of ombitasvir\/paritaprevir\/ritonavir\/ribavirin in management of HCV genotype 4 and end-stage kidney disease. Clini Res Hepatol Gas. 2019;43(1):82\u20137.","journal-title":"Clini Res Hepatol Gas"},{"key":"9126_CR20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.micpath.2019.01.004","volume":"128","author":"VK Chaturvedi","year":"2019","unstructured":"Chaturvedi VK, Singh A, Dubey SK, Hetta HF, John J, Singh M. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microb Pathog. 2019;128:184\u201394.","journal-title":"Microb Pathog"},{"key":"9126_CR21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/IDR.S181638","volume":"12","author":"MA Mekky","year":"2019","unstructured":"Mekky MA, Sayed HI, Abdelmalek MO, Saleh MA, Osman OA, Osman HA, et al. Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir\/daclatasvir therapy: a multi-center study. Infect Drug Resist. 2019;12:273.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"9126_CR22","first-page":"79","volume":"24","author":"HF Hetta","year":"2017","unstructured":"Hetta HF, Elkady A, Morsy KH, Mohamed IS, Ibrahim MA. Serum level of IL17a among cirrhotic hepatitis C virus infected patients with incidence of diabetes mellitus. Egypt J Immunol. 2017;24(1):79\u201388.","journal-title":"Egypt J Immunol"},{"issue":"3","key":"9126_CR23","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.20546\/ijcmas.2017.603.225","volume":"6","author":"HF Hetta","year":"2017","unstructured":"Hetta HF. Circulating IL17A and IFN-gamma serum levels in cirrhotic hepatitis C virus infected patients with autoimmune thyroiditis. Int J Curr Microbiol App Sci. 2017;6(3):1972\u201383.","journal-title":"Int J Curr Microbiol App Sci"},{"issue":"8","key":"9126_CR24","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.20546\/ijcmas.2017.608.301","volume":"6","author":"HF Hetta","year":"2017","unstructured":"Hetta HF, Elkady A, Meshaal AK. TH17\/TH1 role in endocrine disorders among chronic HCV infected patients. Int J Curr Microbiol App Sci. 2017;6(8):2542\u201351.","journal-title":"Int J Curr Microbiol App Sci"},{"issue":"11","key":"9126_CR25","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jclinpath-2013-201581","volume":"66","author":"MTM Shata","year":"2013","unstructured":"Shata MTM, Abdel-Hameed EA, Hetta HF, Sherman KE. Immune activation in HIV\/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). J Clin Pathol. 2013;66(11):967\u201375.","journal-title":"J Clin Pathol"},{"issue":"7203","key":"9126_CR26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344.","journal-title":"Nature"},{"key":"9126_CR27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cyto.2016.10.004","volume":"89","author":"I Sghaier","year":"2017","unstructured":"Sghaier I, Mouelhi L, Rabia NA, Alsaleh BR, Ghazoueni E, Almawi WY, et al. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients. Cytokine. 2017;89:62\u20137.","journal-title":"Cytokine"},{"issue":"5","key":"9126_CR28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/1533034616672806","volume":"16","author":"H Liu","year":"2017","unstructured":"Liu H, Lyu D, Zhang Y, Sheng L, Tang N. Association between the IL-6 rs1800795 polymorphism and the risk of cervical cancer: a meta-analysis of 1210 cases and 1525 controls. Technology in cancer research & treatment. 2017;16(5):662\u20137.","journal-title":"Technology in cancer research & treatment"},{"issue":"4","key":"9126_CR29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ajme.2018.08.001","volume":"54","author":"AH Ad\u2019hiah","year":"2018","unstructured":"Ad\u2019hiah AH, Mahmood AS, Al-kazaz A-KA, Mayouf KK. Gene expression and six single nucleotide polymorphisms of interleukin-6 in rheumatoid arthritis: a case-control study in Iraqi patients. Alexandria J Med. 2018;54(4):639\u201345.","journal-title":"Alexandria J Med"},{"key":"9126_CR30","first-page":"69","volume":"26","author":"EA Hassan","year":"2019","unstructured":"Hassan EA, Ahmed EH, Nafee AM, El-Gafary N, Hetta HF, El-Mokhtar MA. Regulatory T cells, IL10 and IL6 in HCV related hepatocellular carcinoma after transarterial chemoembolization (TACE). Egypt J Immunol. 2019;26:69\u201378.","journal-title":"Egypt J Immunol"},{"issue":"1","key":"9126_CR31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal MR, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19(1):683\u2013765.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"9126_CR32","doi-asserted-by":"crossref","first-page":"00136","DOI":"10.15406\/ghoa.2016.05.00136","volume":"5","author":"H Hetta","year":"2016","unstructured":"Hetta H, Elkady A, Tohamy T, Badary M. Regulatory B cells: key players in hepatocellular carcinoma progression. Gastroenterol Hepatol Open Access. 2016;5(2):00136.","journal-title":"Gastroenterol Hepatol Open Access"},{"issue":"1","key":"9126_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ijc.2910550118","volume":"55","author":"GA Gastl","year":"1993","unstructured":"Gastl GA, Abrams JS, Nanus DM, Oosterkamp R, Silver J, Liu F, et al. Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer. 1993;55(1):96\u2013101. https:\/\/doi.org\/10.1002\/ijc.2910550118.","journal-title":"Int J Cancer"},{"issue":"9","key":"9126_CR34","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/jmv.24501","volume":"88","author":"DC Aroucha","year":"2016","unstructured":"Aroucha DC, Carmo RF, Vasconcelos LRS, Lima RE, Mendon\u00e7a TF, Arnez LE, et al. TNF-\u03b1 and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals. J Med Virol. 2016;88(9):1587\u201395.","journal-title":"J Med Virol"},{"issue":"2","key":"9126_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/bmfj.bmfj_1_17","volume":"34","author":"F Abd El Salam","year":"2017","unstructured":"Abd El Salam F, El Toukhy N, Mohamed A, Nekola H. Serum interleukin-6 concentration and association with response to hepatitis C virus therapy for chronic hepatitis C patients. Benha Med J. 2017;34(2):59\u201365. https:\/\/doi.org\/10.4103\/bmfj.bmfj_1_17.","journal-title":"Benha Med J"},{"issue":"4","key":"9126_CR36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/vim.2015.0093","volume":"29","author":"EA Abdel-Hameed","year":"2016","unstructured":"Abdel-Hameed EA, Rouster SD, Ji H, Ulm A, Hetta HF, Anwar N, et al. Evaluating the role of cellular immune responses in the emergence of HCV NS3 resistance mutations during protease inhibitor therapy. Viral Immunol. 2016;29(4):252\u20138.","journal-title":"Viral Immunol"},{"issue":"15","key":"9126_CR37","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-06-0154","volume":"12","author":"G Feldmann","year":"2006","unstructured":"Feldmann G, Nischalke HD, Nattermann J, Banas B, Berg T, Teschendorf C, et al. Induction of Interleukin-6 by hepatitis C virus core protein in hepatitis C\u2013associated mixed cryoglobulinemia and B-cell non\u2013Hodgkin's lymphoma. Clin Cancer Res. 2006;12(15):4491\u20138.","journal-title":"Clin Cancer Res"},{"issue":"2\u20133","key":"9126_CR38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12026-019-09075-x","volume":"67","author":"AM Zahran","year":"2019","unstructured":"Zahran AM, Zahran ZAM, El-Badawy O, Abdel-Rahim MH, Ali WA, Rayan A, et al. Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma. Immunol Res. 2019;67(2\u20133):157\u201365.","journal-title":"Immunol Res"},{"issue":"5","key":"9126_CR39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1373\/clinchem.2007.098608","volume":"54","author":"AJ Smith","year":"2008","unstructured":"Smith AJ, D\u2019Aiuto F, Palmen J, Cooper JA, Samuel J, Thompson S, et al. Association of serum interleukin-6 concentration with a functional IL6\u2212 6331T> C polymorphism. Clin Chem. 2008;54(5):841\u201350.","journal-title":"Clin Chem"},{"issue":"4\u20135","key":"9126_CR40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6101(02)00027-8","volume":"13","author":"K Ishihara","year":"2002","unstructured":"Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13(4\u20135):357\u201368.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"9126_CR41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/omi.2010.0093","volume":"15","author":"L Giannitrapani","year":"2011","unstructured":"Giannitrapani L, Soresi M, Giacalone A, Campagna ME, Marasa M, Cervello M, et al. IL-6\u2212174G\/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. Omics. 2011;15(3):183\u20136.","journal-title":"Omics"},{"issue":"4","key":"9126_CR42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archsurg.1996.01430160018002","volume":"131","author":"JS Reichner","year":"1996","unstructured":"Reichner JS, Mulligan JA, Palla ME, Hixson DC, Albina JE, Bland KI. Interleukin-6 production by rat hepatocellular carcinoma cells is associated with metastatic potential but not with tumorigenicity. Arch Surg. 1996;131(4):360\u20135.","journal-title":"Arch Surg"},{"issue":"1","key":"9126_CR43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/hep.24052","volume":"53","author":"NH Afdhal","year":"2011","unstructured":"Afdhal NH, McHutchison JG, Zeuzem S, Mangia A, Pawlotsky JM, Murray JS, et al. Hepatitis C pharmacogenetics: state of the art in 2010. Hepatology. 2011;53(1):336\u201345. https:\/\/doi.org\/10.1002\/hep.24052.","journal-title":"Hepatology"},{"issue":"5","key":"9126_CR44","first-page":"379","volume":"83","author":"M Malaguarnera","year":"1996","unstructured":"Malaguarnera M, Di IF, Laurino A, Romeo M, Giugno I, Trovato B. Role of interleukin 6 in hepatocellular carcinoma. Bull Cancer. 1996;83(5):379\u201384.","journal-title":"Bull Cancer"},{"issue":"6","key":"9126_CR45","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s11136-019-02129-5","volume":"28","author":"DA Vieira","year":"2019","unstructured":"Vieira DA, da Cunha LR, da Silva CB, Almeida MTB, Gomes AD, de Faria CLL, et al. The combined polymorphisms of interleukin-6-174GG genotype and interleukin-10 ATA haplotype are associated with a poor quality of life in patients with chronic hepatitis C. Qual Life Res. 2019;28(6):1531\u201342. https:\/\/doi.org\/10.1007\/s11136-019-02129-5.","journal-title":"Qual Life Res"},{"issue":"3","key":"9126_CR46","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","volume":"178","author":"A D'Andrea","year":"1993","unstructured":"D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells. J Exp Med. 1993;178(3):1041\u20138. https:\/\/doi.org\/10.1084\/jem.178.3.1041.","journal-title":"J Exp Med"},{"issue":"1","key":"9126_CR47","first-page":"34","volume":"66","author":"FH Shaikh","year":"2016","unstructured":"Shaikh FH, Zeb S, Chandio SA, Munaf A, Ghori MA, Memon MS, et al. Frequency of deaths in hepatitis C virus infected hepatocellular carcinoma patients and its relationship with raised serum alpha-fetoprotein levels. J Pak Med Assoc. 2016;66(1):34\u20136.","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"9126_CR48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdermsci.2004.10.002","volume":"37","author":"K Kingo","year":"2005","unstructured":"Kingo K, R\u00e4tsep R, K\u00f5ks S, Karelson M, Silm H, Vasar E. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. J Dermatol Sci. 2005;37(2):111\u20133.","journal-title":"J Dermatol Sci"},{"issue":"39","key":"9126_CR49","doi-asserted-by":"publisher","first-page":"66204","DOI":"10.18632\/oncotarget.19857","volume":"8","author":"H Chen","year":"2017","unstructured":"Chen H, Tang J, Shen N, Ren K. Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer. Oncotarget. 2017;8(39):66204\u201314. https:\/\/doi.org\/10.18632\/oncotarget.19857.","journal-title":"Oncotarget"},{"issue":"6","key":"9126_CR50","first-page":"709","volume":"40","author":"Q Gao","year":"2011","unstructured":"Gao Q, Zhang S, Wu L, Jia M, Mi Y, Liu D. Association of IL-10-1082 and IL-10-592 polymorphisms with chronic hepatitis B and\/or hepatitis C virus infection among plasma donors in a rural area of Hebei Province, China. Wei sheng yan jiu = Journal of hygiene research. 2011;40(6):709\u201313.","journal-title":"Wei sheng yan jiu = Journal of hygiene research"},{"issue":"5","key":"9126_CR51","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1007\/s10620-014-3358-1","volume":"60","author":"Y Gong","year":"2015","unstructured":"Gong Y, Zhao C, Zhao P, Wang M, Zhou G, Han F, et al. Role of IL-10-producing regulatory B cells in chronic hepatitis B virus infection. Dig Dis Sci. 2015;60(5):1308\u201314. https:\/\/doi.org\/10.1007\/s10620-014-3358-1.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"9126_CR52","first-page":"11680","volume":"8","author":"L Yao","year":"2015","unstructured":"Yao L, Xing S, Fu X, Song H, Wang Z, Tang J, et al. Association between interleukin-10 gene promoter polymorphisms and susceptibility to liver cirrhosis. Int J Clin Exp Pathol. 2015;8(9):11680\u20134.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"9126_CR53","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1053\/jhep.2003.50427","volume":"38","author":"DR Nelson","year":"2003","unstructured":"Nelson DR, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu YL, et al. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology. 2003;38(4):859\u201368. https:\/\/doi.org\/10.1053\/jhep.2003.50427.","journal-title":"Hepatology"},{"issue":"2","key":"9126_CR54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3329\/bjms.v15i2.19602","volume":"15","author":"SS Haque","year":"2016","unstructured":"Haque SS, Kumari R, Muzaffar A, Kumar U, Sharan A, Kumari B. Estimation of serum alpha feto-protein (AFP), interlukin-6 and Des-?-carboxyprothrombin (DCP) in case of hepatocellular carcinoma. Bangladesh Journal of Medical Science. 2016;15(2):230\u20133.","journal-title":"Bangladesh Journal of Medical Science"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-020-09126-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09126-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T23:46:29Z","timestamp":1622763989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-020-09126-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9126"],"URL":"https:\/\/doi.org\/10.1007\/s12026-020-09126-8","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"4 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with ethical guidelines of the 1975 Helsinki Declaration and was approved by the local ethics committee of Faculty of Medicine, Assiut University. A written informed consent was taken from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}